Larry L. Wood - 10 Nov 2021 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP, TAVR
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
10 Nov 2021
Net transactions value
-$662,366
Form type
4
Filing time
10 Nov 2021, 16:38:22 UTC
Previous filing
12 Oct 2021
Next filing
10 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $275,590 +7,830 +2.1% $35.20 379,964 10 Nov 2021 Direct F1
transaction EW Common Stock Sale $937,956 -7,830 -2.1% $119.79 372,134 10 Nov 2021 Direct F1
holding EW Common Stock 496 10 Nov 2021 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -7,830 -50% $0.000000 7,830 10 Nov 2021 Common Stock 7,830 $35.20 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021.
F2 Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.